REFERENCES
- Food and Drug Administration. Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. U.S. Food and Drug Administration, 1997.
- European Agency for the Evaluation of Medicinal Products Note for Guidance on Quality of Modified Release Products: A: Oral Dosage Forms B: Transdermal Dosage Forms. European Medicines Agency, 2000.
- Leeson L J. In vitro/in vivo correlations. Drug Inf J 1995; 29:903–915.
- Liu Y, Schwartz J B, Schnaare R L, Sugita E T. A multi-mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlations. Pharm Dev Technol 2003; 8:409–417. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sirisuth N, Augsburger L L, Eddington N D. Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation. Biopharm Drug Dispos 2002; 23:1–8. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cardot J M, Beyssac E. In vitro/in vivo correlations: scientific implications and standardisation. Eur J Drug Metab Pharmacokinet 1993; 18:113–120. [PUBMED], [INFOTRIEVE]
- Hussein Z, Friedman M. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation. Pharm Res 1990; 7:1167–1171. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hayes S, Dunne A, Smart T, Davis J. Interpretation and Optimization of the Dissolution Specifications for a Modified Release Product with an In Vivo-In Vitro Correlation IVIVC. J Pharm Sci 2004; 93:571–581. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Devane J. The impact of in vitro-in vivo relationships on product development. Adv Exp Med Biol 1997; 423:241–260. [PUBMED], [INFOTRIEVE], [CSA]
- Welling P G, Forgue S T, Cook J A, DeVries T M. In vitro-in vivo correlations—quo vadis. Drug Inf J 1995; 29:893–902.
- Polli J E, Crison J R, Amidon G L. Novel approach to the analysis of in vitro-in vivo relationships. J Pharm Sci 1996; 85:753–760. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gillespie W R. Convolution-based approaches for in vivo-in vitro correlation modelling. Adv Exp Med Biol 1997; 423:53–65. [PUBMED], [INFOTRIEVE], [CSA]
- Dunne A, O'Hara T, Devane J. Approaches to IVIVR modelling and statistical analysis. Adv Exp Med Biol 1997; 423:67–86. [PUBMED], [INFOTRIEVE], [CSA]
- Dowell J A, Hussain A, Devane J, Young D. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. J Pharm Sci 1999; 88:154–160. [PUBMED], [INFOTRIEVE], [CROSSREF]
- O'Hara T, Hayes S, Davis J, Devane J, Smart T, Dunne A. In vivo-in vitro correlation IVIVC modelling incorporating a convolution step. J Pharmacokinet Pharmacodyn 2001; 28:277–298. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Buchwald P. Direct, differential-equation-based in-vitro-in-vivo correlation IVIVC method. J Pharm Pharmacol 2003; 55:495–504. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Humbert H, Cabiac M D, Bosshardt H. In vitro-in vivo correlation of a modified release oral form of ketotifen: in vitro dissolution rate specification. J Pharm Sci 1994; 83:131–136. [PUBMED], [INFOTRIEVE]
- Hwang S S, Gorsline J, Louie J, Dye D, Guinta D, Hamel L. In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product. J Clin Pharmacol 1995; 35:259–267. [PUBMED], [INFOTRIEVE], [CSA]
- Mauger D T, Chinchilli V M. In vitro-in vivo relationships for oral extended-release drug products. J Biopharm Stat 1997; 7:565–578. [PUBMED], [INFOTRIEVE], [CSA]
- Modi N B, Lam A, Lindemulder E, Wang B, Gupta S K. Application of in vitro-in vivo correlations IVIVC in setting formulation release specifications. Biopharm Drug Dispos 2000; 21:321–326. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pitsiu M, Sathyan G, Gupta S, Verotta D. A semi parametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin. J Pharm Sci 2001; 90:702–712. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Corrigan O I, Devlin Y, Butler J. Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation. Int J Pharm 2003; 254:147–154. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Takka S, Sakr A, Goldberg A. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. J Control Release 2003; 88:147–157. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- United States Pharmacopeia. Chapter <711> Dissolution, U.S. Pharmacopeial Convention, Rockville, MD, 1995; 1791–1797.
- Banakar U V, Makoid M C. Drug Dissolution and Bioavailability. Lancaster, PA: Technomic, 1994.
- Gillespie W R. PCDCON: Deconvolution for pharmacokinetic applications. Documentation for PCDCON computer program. University of Texas at Austin
- Madden F N, Godfrey K R, Chappell M J, Hovorka R, Bates R A. A comparison of six deconvolution techniques. J Pharmacokinet Biopharm 1996; 24:283–299. [PUBMED], [INFOTRIEVE], [CSA]
- Karasulu E, Aktogu S, Karasulu H Y, Aydogdu A, Tugular I, Ertan G. Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets. Eur J Drug Metab Pharmacokinet 2003; 28:301–307. [PUBMED], [INFOTRIEVE], [CSA]
- Bigora S, Piscitelli D, Dowell J, Butler J, Farrell C, Devane J, Young D. Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations. Adv Exp Med Biol 1997; 423:207–215. [PUBMED], [INFOTRIEVE], [CSA]
- Dunne A, Devane J, O'Hara T. The relationship between in vitro drug dissolution and in vivo absorption. Statistician 1999; 48:125–133.
- Young D, Devane J G, Butler J. Advances in experimental medicine and biology.In Vitro-In Vivo Correlations. Vol. 423. Plenum Press: New York, 1997.
- Polli J E. IVIVR versus IVIVC. Dissol Technol 2000; 7:6–16.
- Rostami-Hodjegan A, Shiran M R, Tucker G T, Conway B R, Irwin W J, Shaw L R, Grattan T J. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev Ind Pharm 2002; 28:533–543. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Balan G, Timmins P, Greene D S, Marathe P H. In vitro-in vivo correlation IVIVC models for metformin after administration of modified-release MR oral dosage forms to healthy human volunteers. J Pharm Sci 2001; 90:1176–1185. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kortejarvi H, Mikkola J, Bacjman M, Antila S, Marvola M. Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules. Int J Pharm 2002; 241:87–95. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Snedecor G W, Cochran W G. Statistical Methods. 7th ed. Ames, IO: Iowa State University Press, 1980.
- Diggle P J, Liang K Y, Zeger S L. Analysis of Longitudinal Data. Oxford: Oxford University Press, 1996.
- Wing G M. A Primer on Integral Equations of the First Kind—The Problem of Deconvolution and Unfolding. Philadelphia: Society for Industrial and Applied Mathematics, 1991.